Sign in

2022-500041-24-00RecruitingPhase 1/2

SPRING Rollover

Source: EU CTIS (euclinicaltrials.eu) · Last updated 1 Jun 2022 · Not updated for over 12 months - ask the site whether it is still open

Status (registry)
Recruiting
Phase (registry)
Phase 1/2
Study type
Interventional
Enrollment
1 (estimated)
First submitted
1 Apr 2022
Start date
27 Sept 2022
Lead sponsor
Worldwide Innovative Network
Diseases
Lung cancer
EU CT number
2022-500041-24-00

What you commit to

  • Study type: Interventional · Phase 1/2
  • Planned participants: 1
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Vall d'Hebron Institute of Oncology
Coordinator of this site? Confirm its status
BarcelonaSpainRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.